Humabiologics

Humabiologics is a private, early-revenue company positioned as a supplier of critical human-derived biomaterials for advanced life science research. Its core value proposition addresses the historical limitations of animal-derived or synthetic alternatives by providing a stable, ethical, and clinically relevant supply of native human ECM and collagen. The company targets the rapidly growing fields of regenerative medicine, drug testing, and 3D tissue modeling, enabling more physiologically accurate research. Its business model is platform-based, providing essential research tools rather than developing its own therapeutics.

Proprietary platform for ethically sourcing and processing donated human tissue into native, lyophilized extracellular matrix (ECM), collagen, and customizable bioinks for research and bioprinting.

Humabiologics competes with large life science suppliers like Corning (rat tail collagen) and Thermo Fisher, as well as companies offering bovine or porcine ECM (e.g., Advanced Biomatrix). Its primary differentiation is the native, human origin of its materials. Synthetic hydrogel providers (e.g., Cellink, now BICO) offer consistency and tunability but lack native biological signals. Humabiologics occupies a unique niche by bridging the gap between biological relevance and commercial availability.